Involvement of FGFR4 in Pulmonary Fibrosis Pathophysiology

被引：0
|
作者：
Ghanem, M. [1 ]
Justet, A. [1 ]
Jaillet, M. [1 ]
Hachem, M. [1 ]
Boghanim, T. [1 ]
Vadel, A. [1 ]
Mailleux, A. [1 ]
Crestani, B. [2 ]
机构：
[1] INSERM, U1152, Paris, France
[2] Hop Bichat Claude Bernard, Serv Pneumol, Paris, France
来源：
AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE | 2021年 / 203卷 / 09期
关键词：
D O I：
暂无
中图分类号：
R4 [临床医学];
学科分类号：
1002 ; 100602 ;
摘要：
A4220
引用
收藏
页数：1
相关论文
共 50 条
  • [1] Identification of FGFR4 as a regulator of myofibroblast differentiation in pulmonary fibrosis
    Ghanem, Mada
    Justet, Aurelien
    Jaillet, Madeleine
    Vasarmidi, Eirini
    Boghanim, Tiara
    Hachem, Mouna
    Vadel, Aurelie
    Joannes, Audrey
    Mordant, Pierre
    Balayev, Agshin
    Adams, Taylor
    Mal, Herve
    Cazes, Aurelie
    Pote, Nicolas
    Mailleux, Arnaud
    Crestani, Bruno
    AMERICAN JOURNAL OF PHYSIOLOGY-LUNG CELLULAR AND MOLECULAR PHYSIOLOGY, 2024, 327 (06) : L818 - L830
  • [2] Implication of FGFR4 and its ligands in Idiopathic Pulmonary Fibrosis
    Justet, Aurelien
    Demagny, Simon
    Boghanim, Tiara
    Jaillet, Madeleine
    Marchal-Duval, Emmeline
    Cazes, Aurelie
    Mordant, Pierre
    Castier, Yves
    Mailleux, Arnaud
    Crestani, Bruno
    EUROPEAN RESPIRATORY JOURNAL, 2018, 52
  • [3] FGFR4 has pro fibrotic properties in Idiopathic Pulmonary Fibrosis
    Justet, Aurelien
    Ghanem, Mada
    Jaillet, Madeleine
    Hachem, Mouna
    Boghanim, Tiara
    Vadel, Aurelie
    Mailleux, Arnaud
    Crestani, Bruno
    EUROPEAN RESPIRATORY JOURNAL, 2020, 56
  • [4] Exploring the involvement of FGFR4 in hepatocellular carcinoma
    Ho, Han Kiat
    Pok, Sharon
    Ruhe, Jens E.
    Hart, Stefan
    Streit, Sylvia S.
    Loo, Hooi Linn
    Foo, Priscilla
    Do Aung, Myat
    Ullrich, Axel
    Lim, Seng Gee
    MOLECULAR CANCER THERAPEUTICS, 2007, 6 (12) : 3549S - 3550S
  • [5] Fibroblast growth factor receptor 4 (FGFR4) mediates signaling to the prolactin but not the FGFR4 promoter
    Yu, SJ
    Zheng, L
    Asa, SL
    Ezzat, S
    AMERICAN JOURNAL OF PHYSIOLOGY-ENDOCRINOLOGY AND METABOLISM, 2002, 283 (03): : E490 - E495
  • [6] THE ROLE OF FGFR4 IN NEUROBLASTOMA
    Whittle, Sarah
    Du, Melissa
    Zhang, Linna
    Woodfield, Sarah
    Scheurer, Michael
    Okcu, Fatih
    Zage, Peter
    PEDIATRIC BLOOD & CANCER, 2014, 61 : S97 - S98
  • [7] Involvement of FGFR4 Gene Variants on the Clinicopathological Severity in Urothelial Cell Carcinoma
    Tsay, Ming-Dow
    Hsieh, Ming-Ju
    Lee, Chia-Yi
    Wang, Shian-Shiang
    Chen, Chuan-Shu
    Hung, Sheng-Chun
    Lin, Chia-Yen
    Yang, Shun-Fa
    INTERNATIONAL JOURNAL OF ENVIRONMENTAL RESEARCH AND PUBLIC HEALTH, 2020, 17 (01)
  • [8] Targeting FGFR4 for rhabdomyosarcoma immunotherapy
    Cheuk, A. T. C.
    Shivaprasad, N.
    Kumar, J.
    Azorsa, P.
    Skarzynski, M.
    Baskar, S.
    Orentas, R.
    Khan, J.
    EUROPEAN JOURNAL OF CANCER, 2018, 103 : E9 - E10
  • [9] EGFR Inhibition Overcomes Resistance to FGFR4 Inhibition and Potentiates FGFR4 Inhibitor Therapy in Hepatocellular Carcinoma
    Shen, Bin
    Shi, Jue-Ping
    Zhu, Zhi-Xuan
    He, Zhi-Dong
    Liu, Shen-Yan
    Shi, Wan
    Zhang, Yong-Xian
    Ying, Hai-Yan
    Wang, Jie
    Xu, Rui-Feng
    Fang, Fei
    Chang, Harrison Xuesong
    Chen, Zhui
    Zhang, Nan-Nan
    MOLECULAR CANCER THERAPEUTICS, 2023, 22 (12) : 1479 - 1492
  • [10] Involvement Of Tetratricopeptide Repeat Domain 3 In Pathophysiology Of Pulmonary Fibrosis
    Kim, H.
    Park, M.
    Han, J.
    Kim, S.
    Lee, Y. -S.
    AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2014, 189
12345